Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD3759 - Oral EGFR Inhibitor for Cancer Research | APExBIO
AZD3759 CAS#: 1626387-80-1
AZD3759 | CAS:1626387-80-1 | EGFR inhibitor，oral active | High Purity ...
AZD3759 enhances radiation effects in non-small-cell lung cancer by a ...
低剂量 AZD3759 序贯奥希替尼治疗 EGFR 突变肺癌脑转移，高效低毒新方案！_腾讯新闻
AZD3759 mode-ofaction: inhibition of EGFR activation by the ...
Full article: AZD3759 inhibits glioma through the blockade of the ...
Efficacy, safety and dose selection of AZD3759 in patients with ...
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung ...
AZD3759 hydrochloride | EGFR | TargetMol
AZD3759 suppresses the growth of C6 cells in xenograft mice. a. Live ...
AZD3759 promotes the inhibitory effect of RA on the brain metastasis by ...
Buy AZD3759 from LEAP CHEM CO., LTD. - ECHEMI
AZD3759 for CNS metastases in EGFR-mutant lung cancer - The Lancet ...
Enhanced efficacy of AZD3759 and radiation on brain metastasis from ...
Ⅳ 期 EGFR-TKI 治疗后脑膜转移，二线 AZD3759 脑膜病灶消失，腹膜考虑多发转移，后续如何治疗 ？| 龙哥查房医药新闻 ...
RCSB PDB - 9OU9: AZD3759 in complex with wild-type EGFR
Explanation details of the CAS 1626387-80-1 : AZD3759 - EOS Med Chem
Effects of AZD3759 and osimertinib on the sensitivity of NSCLC cells to ...
AZD3759 promoted the RA-induced apoptosis in NSCLC cells. (a) The ...
AZD3759 | EGFR 抑制剂 | 美国进口 | AZD3759 供应商 AdooQ®
AZD3759 (Zorifertinib) hydrochloride (Zorifertinib; AZD-3759 HCl) | CAS ...
Proliferation is suppressed and apoptosis is induced by AZD3759 in ...
AZD3759 vs. EGFR-TKI: Phase II/III Lung Cancer Study | Course Hero
(PDF) AZD3759 inhibits glioma through the blockade of the epidermal ...
AZD3759 1626387-80-1 - ChemicalBook
AZD3759 固体状「CAS号：1626387-80-1」 – 960化工网
AZD3759 | EGFR inhibitor | Axon 2563 | Axon Medchem
JAK1 overexpression abolishes effects of AZD3759 on clone formation and ...
AZD3759 Hydrochloride Manufacturer | Supplier | Exporter
Zorifertinib (AZD3759) | ≥99%(HPLC) | Selleck | EGFR 阻害剤
Zorifertinib (AZD3759) | EGFR inhibitor | Probechem Biochemicals
Pharmacological Inhibition of Brain EGFR Activation By a BBB ...
肺癌入脑靶向药物AZD3759一期临床试验疗效显著 - 知乎
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR ...
【2023 ASCO】吴一龙教授深入解读新型 EGFR 抑制剂AZD3759（佐利替尼）在肺癌脑转移患者中的III期临床数据医药新闻 ...
《ASCO 2023 重磅研究-肺癌篇》：新一代 EGFR 抑制剂AZD3759（佐利替尼）治疗肺癌脑转移Ⅲ期临床研究！_腾讯新闻
AZD3759价格 200元/g 厂家：山东海沃生物科技有限公司
一线治疗肺癌脑转移EGFR-TKI新药：佐利替尼（泽瑞尼、AZD3759），强力穿透血脑屏障 - 知乎
AbMole科研-AZD3759通过协同阻断表皮生长因子受体和Janus激酶-1增强非小细胞肺癌的辐射效应 学术化工
Zorifertinib (AZD3759) | EGFR 抑制剂 | Zorifertinib (AZD3759)供应商 AdooQ®
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral ...
Zorifertinib (AZD3759) | EGFR 阻害剤
AbMole科研-AZD3759通过协同阻断表皮生长因子受体和Janus激酶-1增强非小细胞肺癌的辐射效应_腾讯新闻
AZD3759,CAS:1626387-80-1
AZD3759在EGFR突变的具有CNS转移的非小细胞肺癌（BLOOM）中的活性和安全性：阶段1，开放标签，剂量递增和剂量扩展研究。,The ...
(PDF) Pharmacological Inhibition of Brain EGFR Activation By a BBB ...
AbMole科研-AZD3759通过协同阻断表皮生长因子受体和Janus激酶-1增强非小细胞肺癌的辐射效应 - 知乎
AZD3759-盖德化工网
ASCO速递，DS8201治疗HER2实体瘤有效率高达61.3%，AZD3759有望实现脑转肺癌一线治疗-MedSci.cn
新一代 EGFR 抑制剂AZD3759（佐利替尼）治疗肺癌脑转移II期临床数据出炉！_患者_试验_细胞
Therapeutic targets in traumatic brain injury | DDDT
Professor Myung-Ju Ahn：Zorifertinib (AZD3759) with 100% BBB - Open a ...
左利替尼(AZD3759/Lorlatinib)如何帮助EGFR突变脑转移肺癌患者精准治疗？【康必行海外医疗】
AZD3759（佐利替尼）治疗肺癌脑转移III期临床数据最新公布！
azd3759说明书
Zorifertinib(AZD3759)100%透过血脑屏障_研究
AZD3759-005研究启动会 | 王洁教授：佐利替尼联合三代TKI药物，为EGFR+肺癌脑膜转移患者生命续航医药新闻-ByDrug-一站式 ...
30378-8.jpg)
